MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

23 Oct 2021 Evaluate
The topline surged 99.64% to Rs. 1166.89 millions for the September 2021 quarter as against Rs. 584.51 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 951.27% to Rs. 307.18  millions  from Rs. 29.22 millions in previous same quarter.Operating Profit saw a handsome growth to 368.33 millions from 76.80 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1166.89 584.51 99.64 1166.89 584.51 99.64 1166.89 584.51 99.64
Other Income 25.96 17.35 49.63 25.96 17.35 49.63 25.96 17.35 49.63
PBIDT 368.33 76.80 379.60 368.33 76.80 379.60 368.33 76.80 379.60
Interest 12.24 9.87 24.01 12.24 9.87 24.01 12.24 9.87 24.01
PBDT 356.09 66.93 432.03 356.09 66.93 432.03 356.09 66.93 432.03
Depreciation 20.57 16.83 22.22 20.57 16.83 22.22 20.57 16.83 22.22
PBT 335.52 50.10 569.70 335.52 50.10 569.70 335.52 50.10 569.70
TAX 28.34 20.88 35.73 28.34 20.88 35.73 28.34 20.88 35.73
Deferred Tax -27.07 -4.83 460.46 -27.07 -4.83 460.46 -27.07 -4.83 460.46
PAT 307.18 29.22 951.27 307.18 29.22 951.27 307.18 29.22 951.27
Equity 221.65 80.35 175.86 221.65 80.35 175.86 221.65 80.35 175.86
PBIDTM(%) 31.57 13.14 140.24 31.57 13.14 140.24 31.57 13.14 140.24
Peers
Company Name CMP
Godrej Industries 1063.65
SRF 2469.60
BASF India 3477.55
Pidilite Inds. 1476.00
Tata Chemicals 622.65
View more..